Citation 72686

WU,TS: OU,LF: TENG,CM:. (1994). ARISTOLOCHIC ACIDS, ARISTOLACTAM ALKALOIDS AND AMIDES FROM ARISTOLOCHIA KANKAUENSIS.. 36(4)

Citation Details

Title	ARISTOLOCHIC ACIDS, ARISTOLACTAM ALKALOIDS AND AMIDES FROM ARISTOLOCHIA KANKAUENSIS.
Authors	WU,TS: OU,LF: TENG,CM:
Year	1994
Volume	36
Issue	4

Summary

Year: 1994

Journal: Unknown

Organisms and Their Experiments (1)

Aristolochia kankauensis (ARISTOLOCHIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARISTOLOCHIC ACID II METHYL ESTER	None
2	ANALGESIC ACTIVITY	MEDICINAL FOLKLORE REPORTED FOR	None	None
3	ANTIVENIN EFFECT	MEDICINAL FOLKLORE REPORTED FOR	None	None
4	ANTIASTHMATIC ACTIVITY	MEDICINAL FOLKLORE REPORTED FOR	None	None
5	ANTITUSSIVE ACTIVITY	MEDICINAL FOLKLORE REPORTED FOR	None	None
6	EXPECTORANT ACTIVITY	MEDICINAL FOLKLORE REPORTED FOR	None	None
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLOCHIC ACID II METHYL ESTER	INACTIVE
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLOCHIC ACID II METHYL ESTER	ACTIVE
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLOCHIC ACID II METHYL ESTER	ACTIVE
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLOCHIC ACID II METHYL ESTER	ACTIVE
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLOCHIC ACID II METHYL ESTER	INACTIVE
12	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PHENANTHRENE-1-CARBOXYLIC ACID,3-HYDROXY-4-METHOXY-10-NITRO: METHYL ESTER	None
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PHENANTHRENE-1-CARBOXYLIC ACID,3-HYDROXY-4-METHOXY-10-NITRO: METHYL ESTER	INACTIVE
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PHENANTHRENE-1-CARBOXYLIC ACID,3-HYDROXY-4-METHOXY-10-NITRO: METHYL ESTER	ACTIVE
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PHENANTHRENE-1-CARBOXYLIC ACID,3-HYDROXY-4-METHOXY-10-NITRO: METHYL ESTER	WEAK ACTIVITY
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PHENANTHRENE-1-CARBOXYLIC ACID,3-HYDROXY-4-METHOXY-10-NITRO: METHYL ESTER	WEAK ACTIVITY
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PHENANTHRENE-1-CARBOXYLIC ACID,3-HYDROXY-4-METHOXY-10-NITRO: METHYL ESTER	WEAK ACTIVITY
18	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENANTHRENE-1-CARBOXYLIC ACID,3-HYDROXY-4-METHOXY-10-NITRO: METHYL ESTER	WEAK ACTIVITY
19	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENANTHRENE-1-CARBOXYLIC ACID,3-HYDROXY-4-METHOXY-10-NITRO: METHYL ESTER	ACTIVE
20	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENANTHRENE-1-CARBOXYLIC ACID,3-HYDROXY-4-METHOXY-10-NITRO: METHYL ESTER	ACTIVE
21	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENANTHRENE-1-CARBOXYLIC ACID,3-HYDROXY-4-METHOXY-10-NITRO: METHYL ESTER	ACTIVE
22	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARISTOLOCHIC ACID IV METHYL ESTER	None
23	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARISTOLOCHIC ACID II	None
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLOCHIC ACID II	INACTIVE
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLOCHIC ACID II	WEAK ACTIVITY
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLOCHIC ACID II	INACTIVE
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLOCHIC ACID II	WEAK ACTIVITY
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLOCHIC ACID II	INACTIVE
29	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLOCHIC ACID II	INACTIVE
30	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLOCHIC ACID II	INACTIVE
31	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLOCHIC ACID II	INACTIVE
32	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLOCHIC ACID II	INACTIVE
33	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARISTOLOCHIC ACID I	None
34	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLOCHIC ACID I	ACTIVE
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLOCHIC ACID I	ACTIVE
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLOCHIC ACID I	WEAK ACTIVITY
37	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLOCHIC ACID I	STRONG ACTIVITY
38	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLOCHIC ACID I	ACTIVE
39	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLOCHIC ACID I	INACTIVE
40	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLOCHIC ACID I	INACTIVE
41	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLOCHIC ACID I	INACTIVE
42	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLOCHIC ACID I	INACTIVE
43	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARISTOLOCHIC ACID III-A	None
44	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLOCHIC ACID III-A	INACTIVE
45	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLOCHIC ACID III-A	WEAK ACTIVITY
46	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLOCHIC ACID III-A	INACTIVE
47	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLOCHIC ACID III-A	WEAK ACTIVITY
48	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLOCHIC ACID III-A	EQUIVOCAL
49	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLOCHIC ACID III-A	INACTIVE
50	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLOCHIC ACID III-A	INACTIVE
51	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLOCHIC ACID III-A	WEAK ACTIVITY
52	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLOCHIC ACID III-A	INACTIVE
53	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARISTOLOCHIC ACID IV	None
54	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARISTOLOCHIC ACID III	None
55	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARISTOLOCHIC ACID IV-A	None
56	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CEPHARANONE A	None
57	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CEPHARANONE A	ACTIVE
58	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CEPHARANONE A	ACTIVE
59	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CEPHARANONE A	ACTIVE
60	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CEPHARANONE A	ACTIVE
61	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CEPHARANONE A	ACTIVE
62	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHARANONE A	WEAK ACTIVITY
63	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHARANONE A	INACTIVE
64	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHARANONE A	INACTIVE
65	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHARANONE A	INACTIVE
66	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARISTOLACTAM A-III	None
67	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM A-III	WEAK ACTIVITY
68	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM A-III	ACTIVE
69	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM A-III	ACTIVE
70	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM A-III	ACTIVE
71	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM A-III	ACTIVE
72	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLACTAM A-III	ACTIVE
73	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLACTAM A-III	INACTIVE
74	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLACTAM A-III	ACTIVE
75	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLACTAM A-III	ACTIVE
76	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARISTOLACTAM	None
77	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM	ACTIVE
78	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM	ACTIVE
79	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM	ACTIVE
80	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM	ACTIVE
81	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM	ACTIVE
82	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLACTAM	INACTIVE
83	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLACTAM	WEAK ACTIVITY
84	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLACTAM	WEAK ACTIVITY
85	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLACTAM	WEAK ACTIVITY
86	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARISTOLACTAM I,9-METHOXY:	None
87	Not specified	ISOLATION AND IDENTIFICATION OF	ARISTOLACTAM III	None
88	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM III	WEAK ACTIVITY
89	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM III	ACTIVE
90	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM III	WEAK ACTIVITY
91	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM III	WEAK ACTIVITY
92	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM III	WEAK ACTIVITY
93	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLACTAM III	INACTIVE
94	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLACTAM III	INACTIVE
95	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLACTAM III	INACTIVE
96	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLACTAM III	INACTIVE
97	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARISTOLACTAM A-II	None
98	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM A-II	INACTIVE
99	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM A-II	ACTIVE
100	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM A-II	ACTIVE
101	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM A-II	WEAK ACTIVITY
102	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM A-II	WEAK ACTIVITY
103	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARISTOLACTAM B-III	None
104	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARISTOLACTAM-N-BETA-D-GLUCOSIDE	None
105	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM-N-BETA-D-GLUCOSIDE	INACTIVE
106	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM-N-BETA-D-GLUCOSIDE	ACTIVE
107	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM-N-BETA-D-GLUCOSIDE	WEAK ACTIVITY
108	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLACTAM-N-BETA-D-GLUCOSIDE	INACTIVE
109	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLACTAM-N-BETA-D-GLUCOSIDE	INACTIVE
110	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLACTAM-N-BETA-D-GLUCOSIDE	INACTIVE
111	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLACTAM-N-BETA-D-GLUCOSIDE	INACTIVE
112	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARISTOLACTAM C N-BETA-D-GLUCOSIDE	None
113	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM C N-BETA-D-GLUCOSIDE	INACTIVE
114	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM C N-BETA-D-GLUCOSIDE	ACTIVE
115	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM C N-BETA-D-GLUCOSIDE	WEAK ACTIVITY
116	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM C N-BETA-D-GLUCOSIDE	WEAK ACTIVITY
117	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISTOLACTAM C N-BETA-D-GLUCOSIDE	WEAK ACTIVITY
118	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLACTAM C N-BETA-D-GLUCOSIDE	INACTIVE
119	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLACTAM C N-BETA-D-GLUCOSIDE	INACTIVE
120	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLACTAM C N-BETA-D-GLUCOSIDE	INACTIVE
121	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISTOLACTAM C N-BETA-D-GLUCOSIDE	INACTIVE
122	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CEPHARADIONE A	None
123	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PARABEN,METHYL:	None
124	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	VANILLIC ACID METHYL ESTER	None
125	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CINNAMIC ACID,4-HYDROXY: METHYL ESTER	None
126	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FERULIC ACID METHYL ESTER	None
127	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TYRAMINE,N-TRANS-FERULOYL:	None
128	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TYRAMINE,N-CIS-FERULOYL:	None
129	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TYRAMINE,N-PARA-COUMAROYL:	None
130	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ALLANTOIN	None
131	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ALLANTOIN	ACTIVE
132	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ALLANTOIN	ACTIVE
133	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ALLANTOIN	ACTIVE
134	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ALLANTOIN	ACTIVE
135	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ALLANTOIN	ACTIVE
136	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALLANTOIN	INACTIVE
137	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALLANTOIN	INACTIVE
138	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALLANTOIN	INACTIVE
139	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALLANTOIN	INACTIVE
140	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ARISKANIN A	None
141	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN A	WEAK ACTIVITY
142	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN A	WEAK ACTIVITY
143	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN A	INACTIVE
144	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN A	ACTIVE
145	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN A	INACTIVE
146	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISKANIN A	INACTIVE
147	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISKANIN A	ACTIVE
148	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISKANIN A	ACTIVE
149	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISKANIN A	ACTIVE
150	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ARISKANIN B	None
151	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN B	ACTIVE
152	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN B	ACTIVE
153	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN B	ACTIVE
154	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN B	ACTIVE
155	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN B	ACTIVE
156	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISKANIN B	INACTIVE
157	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISKANIN B	ACTIVE
158	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISKANIN B	ACTIVE
159	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISKANIN B	ACTIVE
160	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ARISKANIN C	None
161	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN C	WEAK ACTIVITY
162	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN C	WEAK ACTIVITY
163	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN C	ACTIVE
164	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN C	WEAK ACTIVITY
165	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN C	WEAK ACTIVITY
166	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISKANIN C	WEAK ACTIVITY
167	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISKANIN C	ACTIVE
168	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISKANIN C	ACTIVE
169	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISKANIN C	ACTIVE
170	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ARISKANIN D	None
171	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN D	ACTIVE
172	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN D	ACTIVE
173	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN D	WEAK ACTIVITY
174	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN D	ACTIVE
175	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN D	ACTIVE
176	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISKANIN D	INACTIVE
177	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISKANIN D	ACTIVE
178	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISKANIN D	ACTIVE
179	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISKANIN D	ACTIVE
180	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ARISKANIN E	None
181	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN E	INACTIVE
182	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN E	ACTIVE
183	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN E	ACTIVE
184	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN E	WEAK ACTIVITY
185	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ARISKANIN E	INACTIVE
186	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISKANIN E	INACTIVE
187	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISKANIN E	ACTIVE
188	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISKANIN E	ACTIVE
189	ANTIPLATELET ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARISKANIN E	WEAK ACTIVITY
190	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	TYRAMINE,N-PARA-CIS-COUMAROYL:	None

Citation 72686

Citation Details

Summary

Organisms and Their Experiments (1)

Aristolochia kankauensis (ARISTOLOCHIACEAE)

Show SPARQL Queries (1)

Query 1